Medistim provides technology for transit time flow measurement (TTFM) used in cardiac, vascular, and transplant surgery. The systems combine ultrasound imaging with flow measurement.

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

COM:MEDISTIM

Medistim

Last Close

135.00

20/11 11:42

Market Cap

3.21B

Beta: -

Volume Today

9.80K

Avg: -

locale

market

industry

website

ipo date

peer of

Metrics